VitalTrace is a medical device company based in Australia, established in 2017. The company's mission is to enhance outcomes for mothers and children during labour and delivery. Their focus is on the development of an innovative fetal monitoring device.
The company secured a recent Series A investment on 21 September 2023, with contributions from Artesian and Fund WA. This investment is a testament to the potential and promise of VitalTrace's technology and its significance in the Information Technology and Medical Devices industries.
VitalTrace's commitment to improving maternal and child healthcare, combined with the support received from Artesian and the Medtech Actuator Program, positions the company as an emerging player in the medical technology sector, with a focus on delivering impactful solutions for an important aspect of healthcare.
No recent news or press coverage available for VitalTrace.